The immune system plays a crucial defense-mechanism role by preventing pathogens and various infectious agents from initiating disease [1]. Homeostasis in the immune system is maintained by immunostimulation and immunosuppression, leading to immune regulation [2]. This defense system classically comprises the two sectors of innate and adaptive immunity [3]. In the non-specific defenses, known as innate immunity, neutrophils, macrophages, natural killer (NK) cells, and dendritic cells perceive exogenous factors and promote the production of cytokines [4]. When macrophages are activated, they eliminate the hazard directly by phagocytosis and indirectly by releasing inflammatory cytokines such as nitric oxide (NO), prostaglandin E 2 (PGE 2 ), tumor necrosis factor-α (TNF-α), and the interleukins . In contrast, the specific defenses, known as adaptive immunity, are characterized by T and B cells [6]. Inflammatory cytokines are also accompanied by the NF-κB and MAPK signaling pathways [7], which are mediated by toll-like receptors (TLRs) [8]. Physiological and pathological responses, including stress responses, inflammation, and apoptosis, are mediated by the MAPK signaling pathway in mammalian cells and tissues [9]. In the MAPK signaling pathway, phosphorylation of p38 MAPK and ERK1/2 plays important roles, activating the production of TNF-α, IL-6, and IL-8, which are inflammatory factors [10]. Moreover, the MAPK cascade and IL-8 secretion are triggered by . In addition to MAPK, NF-κB regulates the expression of proinflammatory mediators. NF-κB p65 protein combines with IκB protein and exists in the cytoplasm. Depending on external stimuli, NF-κB kinases (IKKs) can phosphorylate the IκB family of proteins, followed by ubiquitination and degradation, further phosphorylating p65 and releasing it into the nucleus, where it promotes inflammation.Cyclophosphamide (CP) is a widely used alkylating cytotoxic agent that exerts broad-spectrum activities in modulating immune responses against various illnesses [1,12]. However, administration of high-dose CP can cause immunosuppression and intestinal complications [13]. CP-induced immunosuppression decreases the number
In this study, we evaluated the immune-enhancing activity of kimchi-derivedLactobacillus plantarum 200655 on immune suppression by cyclophosphamide (CP) in ICR mice. Animals were fed distilled water or 1×10 9 colony-forming unit/kg B.W. 200655 or Lactobacillus rhamnosus GG as a positive control for 14 days. An in vivo model of immunosuppression was induced using CP 150 and 100 mg/kg B.W. at 7 and 10 days, respectively. Body weight, spleen index, spleen weight, and gene expression were measured to estimate the immune-enhancing effects. The dead 200655 (D-200655) group showed an increased spleen weight compared to the sham control (SC) group. Similarly, the spleen index was significantly higher than that in the CP-treated group. The live 200655 (L-200655) group showed an increased mRNA expression of tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-6 in splen...